IL-6→Poly(ADP-ribose) Polymerases→Apoptosis Inducing Factor→poly-ADP-ribose

• 18767579(IL-6): [Effect of cranial needling combined with medicine on IL-6 in the patient of acute cerebral hemorrhage]

  CONCLUSION : On the basis of medication , cranial needling can promote rapid decrease of serum IL-6 content and improve nervous function in the patient of acute cerebral hemorrhage.

• 11136941(Poly(ADP-ribose) Polymerases): Inhibition of poly(ADP-ribose) polymerase attenuates cerebral vasospasm after subarachnoid hemorrhage in rabbits.

  BACKGROUND AND PURPOSE : Poly (ADP-ribose) polymerase (PARP) is important in modulating inflammation , which has been implicated in cerebral vasospasm after subarachnoid hemorrhage (SAH).

• 17632284(Apoptosis Inducing Factor): Poly(ADP-ribose) polymerase inhibitor is neuroprotective in epileptic rat via apoptosis-inducing factor and Akt signaling.

  3-Aminobenzamide (3-AB) , an inhibitor of poly (ADP-ribose) polymerase (PARP) , has been proved to have neuroprotective properties.

• 7628865(poly-ADP-ribose): Modulation of inflammatory arthritis by inhibition of poly(ADP ribose) polymerase.

  Our data support the hypothesis that oxidative stress-induced alterations in cellular signal transduction pathways play a pivotal role in the development of arthritis , which can be suppressed by the simultaneous inhibition of poly (ADPR) polymerase and NADPH oxidase.